AUG 19, 2017 12:05 PM PDT

Scientists Map Combination of Mutations that Drive Glioblastoma

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

For disease as complex as cancer, knowing a single mutation is sometimes not enough. In the case of lethal brain tumors, scientists have found many individual mutations, but effective treatments remain elusive.

Instead of honing in on individual mutations, scientists from Yale University are taking a broader approach. That is, they’re interested in how individual mutations coalesce to trigger cancer and drive its progression.

“The human cancer genome is now mapped and thousands of new mutations were associated with cancer, but it has been difficult to prove which ones or their combinations actually cause cancer,” said Sidi Chen, assistant professor of genetics and at Yale’s Systems Biology Institute, and the study’s senior author. “We can also use this information to determine which existing drugs are most likely to have therapeutic value for individual patients, a step towards personalized cancer therapy.’’

In particular, the team is interested in glioblastoma, a highly aggressive cancer of the brain with a meager five-year survival rate of only 10 percent. Chen’s team started with hundreds of genetic mutations already implicated for glioblastoma. They then used CRISPR gene editing and screening technology to study the combinations of these hundreds of mutations. All told, they analyzed over 1500 genetic permutations that could drive glioblastoma progression in mice.

The team found several combinations of mutations, such as B2m–Nf1, Mll3–Nf1 and Zc3h13–Rb1, that could fuel glioblastoma growth. In addition, they identified two mutations in Zc3h13 or Pten, which could explain why some tumors become resistant to the chemotherapy temozolomide.

The results reiterate the complexity of cancer as a genetic disease – that the combination of multiple mutations and pathways are involved in the progression of cancer. Because the whole is greater than the sum of the individual mutations with cancer, this may explain why treatments that only target individual mutations may come up short.

The team hopes their research could help make personalized cancer treatment a reality soon. Furthermore, they say their screening technique could be applied to other cancer types. “Taken together, our study provides a systematic and unbiased molecular landscape of functional tumor suppressors in an autochthonous mouse model of GBM, opening new paths for high-throughput analysis of cancer genetics directly in vivo,” they wrote.

Additional source: Yale UniversityMNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 11, 2021
Cancer
Different Cancer Types Metastasize to Specific Regions of the Brain
OCT 11, 2021
Different Cancer Types Metastasize to Specific Regions of the Brain
Metastatic cancer occurs when cancer spreads from its original site of origin to a distant location in the body. Wh ...
OCT 24, 2021
Microbiology
New Treatment Approach Uses Bacteria to Deliver Drugs to Cancer Cells
OCT 24, 2021
New Treatment Approach Uses Bacteria to Deliver Drugs to Cancer Cells
Bacteria can be found almost everywhere, and they can serve many beneficial purposes. Scientists are now using bacterial ...
NOV 08, 2021
Cancer
Genetic Explanation for Low Cancer Incidence in Elephants
NOV 08, 2021
Genetic Explanation for Low Cancer Incidence in Elephants
Elephants possess two qualities that might make one expect they are at high risk of developing cancer; they are large an ...
NOV 12, 2021
Technology
Available Data for Cancer-Diagnosing AI Lacking Diverse Imagery
NOV 12, 2021
Available Data for Cancer-Diagnosing AI Lacking Diverse Imagery
The use of artificial intelligence to diagnose and monitor health conditions is on the rise. At its most basic level, AI ...
DEC 14, 2021
Neuroscience
Research on Hunger Wins 2021 Eppendorf & Science Prize
DEC 14, 2021
Research on Hunger Wins 2021 Eppendorf & Science Prize
The American scientist Amber L. Alhadeff, Ph.D., Principal Investigator at the Monell Chemical Senses Center and the Uni ...
DEC 23, 2021
Cancer
Optimizing the Recovery Room Could Help Reduce the Recurrence of Bladder Cancer
DEC 23, 2021
Optimizing the Recovery Room Could Help Reduce the Recurrence of Bladder Cancer
It is estimated that nearly 84,000 people will be diagnosed with bladder cancer in the United States this year ...
Loading Comments...